OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ) for the Treatment or Prevention of Alcoholic Liver Disease
Takayuki Koga, Jeffrey M. Peters
Biological and Pharmaceutical Bulletin (2021) Vol. 44, Iss. 11, pp. 1598-1606
Open Access | Times Cited: 6
Takayuki Koga, Jeffrey M. Peters
Biological and Pharmaceutical Bulletin (2021) Vol. 44, Iss. 11, pp. 1598-1606
Open Access | Times Cited: 6
Showing 6 citing articles:
Elevated levels of alcohol dehydrogenase aggravate ethanol-evoked cardiac remodeling and contractile anomalies through FKBP5-yap-mediated regulation of ferroptosis and ER stress
Lu Qi, Xing Qin, Chu Chen, et al.
Life Sciences (2024) Vol. 343, pp. 122508-122508
Closed Access | Times Cited: 17
Lu Qi, Xing Qin, Chu Chen, et al.
Life Sciences (2024) Vol. 343, pp. 122508-122508
Closed Access | Times Cited: 17
Natural products in atherosclerosis therapy by targeting PPARs: a review focusing on lipid metabolism and inflammation
Yan Zhang, Xueying Zhang, Shan-Rui Shi, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 11
Yan Zhang, Xueying Zhang, Shan-Rui Shi, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 11
Targeting PPARs for therapy of atherosclerosis: A review
Miao Miao, Xue Wang, Tian Liu, et al.
International Journal of Biological Macromolecules (2023) Vol. 242, pp. 125008-125008
Closed Access | Times Cited: 22
Miao Miao, Xue Wang, Tian Liu, et al.
International Journal of Biological Macromolecules (2023) Vol. 242, pp. 125008-125008
Closed Access | Times Cited: 22
Exploring the Regulatory Role of ncRNA in NAFLD: A Particular Focus on PPARs
Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Abilash Valsala Gopalakrishnan, et al.
Cells (2022) Vol. 11, Iss. 24, pp. 3959-3959
Open Access | Times Cited: 11
Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Abilash Valsala Gopalakrishnan, et al.
Cells (2022) Vol. 11, Iss. 24, pp. 3959-3959
Open Access | Times Cited: 11
Novel 1,2,4-oxadiazole compounds as PPAR-α ligand agonists: a new strategy for the design of antitumour compounds
Luis Apaza Ticona, Javier Sánchez Sánchez-Corral, A. Sepúlveda, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 7, pp. 1377-1388
Closed Access | Times Cited: 2
Luis Apaza Ticona, Javier Sánchez Sánchez-Corral, A. Sepúlveda, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 7, pp. 1377-1388
Closed Access | Times Cited: 2
Anti-atherosclerotic effects of natural compounds targeting lipid metabolism and inflammation: focus on PPARs, LXRs, and PCSK9
Marcella Palumbo, M. Ugolotti, Francesca Zimetti, et al.
Atherosclerosis Plus (2024)
Open Access
Marcella Palumbo, M. Ugolotti, Francesca Zimetti, et al.
Atherosclerosis Plus (2024)
Open Access
